News

The Trial Interactive PSMF technology is compliant with the legal requirements as outlined in the Commission Implementing Regulation and as detailed in GVP Module II. TransPerfect will offer

Express EDCplus is a comprehensive EDC "technology transfer" program which helps organizations to control the development and implementation timelines of the technology they use to support their clinical

PuraMed has contracted the manufacturing of LipiGesic products to Hillestad Pharmaceuticals, an OTC drug manufacturer, while Unette will pack the bulk material into individual, pre-measured unit dose sachets.

Anmum products including Anmum Materna for pregnant women, contain DHA as their major ingredient. The new study, which included 350 women, was designed to evaluate whether an increased

Orchid has assigned Intellectual Property (IP) related to an antibiotic discovery program to Allecra. Allecra will pursue it then through further trials. According to the deal, Orchid will

Silodosin works by inhibiting the alpha 1A-adrenergic receptor and relieving tension in the prostate, lessening pressure and reducing urethral resistance. Kissei Pharmaceutical discovered silodosin, a selective alpha 1A-adrenoceptor

The approval adds to the company’s planned expansion of the Vascepa manufacturing supply chain and expansion of patent protection for Vascepa in the US. Amarin chairman and chief

The alpha-1 adrenergic receptor agonist Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10% is indicated for dilation of the pupil due to its vasoconstrictor and mydriatic action. Bausch

The small molecule NMDA receptor subunit 2B antagonist MK-0657 will be developed against all human indications, includingdepression. Initially, Merck developed MK-0657 for the treatment of Parkinson’s disease. Cerecor